Otsuka and Lundbeck's new antipsychotic drug Rexulti, built on the foundation of the now off-patent Abilify, has ramped up a new ad campaign begun in mid-February. A scene in the new Rexulti ad While ...
Briefing documents suggest smooth sailing for Rexulti (brexpiprazole) at the meeting to deliberate an application to expand the label of the compound from Otsuka Pharmaceutical Co. Ltd. and Lundbeck A ...
In Q3, the top 10 TV ad spenders poured a combined $544.8 million into airing their commercials, according to data shared ...
The cold and flu brand generated an impressions SOV of 4.71% and 2.9 billion impressions, primarily through CBS and its show GMA 3: What You Need to Know. The Proctor and Gamble brand invested $10.3 ...
PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the ...
NEW ORLEANS — Poster data presented here at Psych Congress indicated three dosages of Rexulti improved depression remission rates among individuals with inadequate response to antidepressants. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback